ReviewPharmaceutics2026

Nose-to-Brain Therapeutics in Parkinson's Disease: Clinical Trials, Mechanisms, and Therapeutic Potential.

Emily Cherny et al.PubMed ↗Publisher ↗

No numbers read from the abstract.